0000950170-23-017874 Sample Contracts

AMENDMENT NO. 1 TO CO-DEVELOPMENT AND OPTION AGREEMENT

Co-Development and Option Agreement • May 4th, 2023 • Alector, Inc. • Biological products, (no disgnostic substances)

• Contract Type
  Co-Development and Option Agreement
• Filed
  May 4th, 2023
• Company
  Alector, Inc.
• Industry
  Biological products, (no disgnostic substances)

This Amendment No. 1 (this “Amendment”) is effective as of February 13, 2023 (the “Amendment Effective Date”) by and between Alector, Inc., a Delaware corporation (“Licensor”), and AbbVie Biotechnology Ltd. (“AbbVie”). Licensor and AbbVie are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”